This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Suppremol Gmbh. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Carolin Direnberger: Innovator in Antibody Research
Introduction
Carolin Direnberger is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of antibody research, particularly in the development of recognition molecules that target specific receptors.
Latest Patents
Carolin holds a patent for "Antibodies directed to Fc gamma receptor IIB and Fc epsilon receptor." This patent discloses recognition molecules that bind with a first binding domain to the Fc epsilon receptor (FcεR) and with a second binding domain to the Fc gamma receptor IIB (FcyRIIB). The implications of this invention are vast, as it opens new avenues for therapeutic applications.
Career Highlights
Carolin is currently employed at Suppremol GmbH, where she continues to advance her research in immunology. Her work has garnered attention for its innovative approach to antibody design and its potential impact on medical treatments.
Collaborations
Throughout her career, Carolin has collaborated with notable colleagues, including Anna Carle and Peter Sondermann. These partnerships have enriched her research and contributed to the success of her projects.
Conclusion
Carolin Direnberger is a trailblazer in the field of antibody research, with a focus on innovative recognition molecules. Her contributions are paving the way for future advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile